Clinical Trial Update: Comparison of Clinical Effects of Azathioprine and Rituximab NMO-SD Patients [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial comparing azathioprine and rituximab in neuromyelitis optica spectrum disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromyelitis Optica Spectrum Disorder

Drugs mentioned

• Azathioprine (azathioprine)
• Rituximab (rituximab)

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: Neuromyelitis Optica Spectrum Disorder | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-09-30